The intermolecular functionalization of olefins presents important challenges of reactivity, regio- and stereoselectivity. A classical solution to these issues is the installation of a tether making use of a functional group on the molecule. The now intramolecular reaction is faster and a cyclic transition state facilitates control over regio- and stereo- selectivity. Nevertheless, this comes at the cost of lower synthetic efficiency, as multiple steps are needed to install and remove the tether. Recently, researchers have begun to address this challenge by developing in situ tethering methods, making this strategy much more attractive (Chem. Sci. 2017, 8, 32. DOI: 10.1039/C6SC04366F ).
Since 2014, we had been attempting to develop an intermolecular version of the palladium-catalyzed oxy- and amino- alkynylation of olefins, but without success. In 2015, we turned to a new in situ-tethering approach based on the formation of half aminals. An efficient one-step procedure for the palladium-catalyzed oxy-alkynylation and arylation of allyl amines could be developed (Angew. Chem., Int. Ed. 2015, 54, 5250. DOI: 10.1002/anie.201500636 ). Key for success was the use of a hemiaminal tether derived from trifluoroacetaldehyde. The enhanced acidity of the half aminal allowed the use of a mild carbonate base.
In 2016, we were able to extend this strategy to the synthesis of diamines via the in situ formation of aminals (Angew. Chem., Int. Ed. 2016, 55, 12881. DOI: 10.1002/anie.201607318 ). The reaction worked well for the introduction of different alkynes groups, as well as electron deficient (hetero)aryls. As the aminal tether and the amine protecting group can be easily removed under acidic conditions, the transformation constitutes a very efficient access to diamines.
In 2017, the strategy could be extended to allylic alcohols, resulting in aminoalcohols with different substitution patterns (Org. Lett. 2017, 19, 3548. DOI: 10.1021/acs.orglett.7b01524 ). In case of the aminoarylation reaction, it was necessary to develop a new Fu-XPhos ligand to suppress a competing Heck pathway.